ERK/MAPK pathways play critical roles in EGFR ligands-induced MMP1 expression
Authors:
- Hae Hyun JungHJHae Hyun Jung
- Yeon Hee ParkYPYeon Hee Park
- Jin Seok AhnJAJin Seok Ahn
- Young-Hyuck ImYIYoung-Hyuck Im
- 1 April 2011
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 407 (4) , 680-686
Abstract
No abstract availableKeywords
Funding Information
- Samsung Biomedical Research Institute (SBRI C-A9-234)
This publication has 23 references indexed in Scilit:
- Mediators of vascular remodelling co-opted for sequential steps in lung metastasisNature, 2007
- Study of matrix metalloproteinases and their inhibitors in breast cancerBritish Journal of Cancer, 2007
- Matrix metalloproteinases and the regulation of tissue remodellingNature Reviews Molecular Cell Biology, 2007
- Structure and function of matrix metalloproteinases and TIMPsCardiovascular Research, 2006
- EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalizationBreast Cancer Research and Treatment, 2005
- Dilating the degradome: matrix metalloproteinase 2 (MMP-2) cuts to the heart of the matterBiochemical Journal, 2004
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Matrix metalloproteinases: they're not just for matrix anymore!Current Opinion in Cell Biology, 2001
- Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancerThe Journal of Pathology, 1998
- Activation of the precursor of gelatinase A/72 kda type IV collagenase/MMP‐2 in lung carcinomas correlates with the expression of membrane‐type matrix metalloproteinase (MT‐MMP) and with lymph node metastasisInternational Journal of Cancer, 1995